Voyager Therapeutics, Inc. (VYGR) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $61.00K; Additional Paid in CapitalUSD $653.05M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-421.00K; Retained Earnings (Accumulated Deficit)USD $-498.31M.
- 2026-03-31: Common Stock, Value, IssuedUSD $60.00K; Additional Paid in CapitalUSD $647.71M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-263.00K; Retained Earnings (Accumulated Deficit)USD $-473.84M.
- 2025-12-31: Common Stock, Value, IssuedUSD $59.00K; Additional Paid in CapitalUSD $641.89M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $32.00K; Retained Earnings (Accumulated Deficit)USD $-445.90M.
- 2025-09-30: Common Stock, Value, IssuedUSD $56.00K; Additional Paid in CapitalUSD $638.24M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $7.00K; Retained Earnings (Accumulated Deficit)USD $-418.48M.
Voyager Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Preferred Stock, Value, Outstanding USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $61.00K | $653.05M | $-421.00K | $-498.31M | $154.38M | 3 month · $2.43M | (m) | (m) |
| 2026-03-31 | $60.00K | $647.71M | $-263.00K | $-473.84M | $173.67M | 3 month · $2.49M | (m) | (m) |
| 2025-12-31 | $59.00K | $641.89M | $32.00K | $-445.90M | $196.08M | 12 month · $14.79M | (m) | (m) |
| 2025-09-30 | $56.00K | $638.24M | $7.00K | $-418.48M | $219.82M | 3 month · $3.46M | (m) | (m) |
| 2025-06-30 | $56.00K | $634.70M | $-221.00K | $-390.59M | $243.94M | 3 month · $4.13M | (m) | (m) |
| 2025-03-31 | $55.00K | $630.05M | $-199.00K | $-357.20M | $272.70M | 3 month · $3.67M | (m) | (m) |
| 2024-12-31 | $55.00K | $626.30M | $-407.00K | $-326.18M | $299.76M | 12 month · $14.46M | (m) | (m) |
| 2024-09-30 | $55.00K | $621.99M | $-33.00K | $-291.70M | $330.31M | 3 month · $3.35M | (m) | (m) |
| 2024-06-30 | $54.00K | $618.54M | $-522.00K | $-282.65M | $335.42M | 3 month · $3.96M | (m) | (m) |
| 2024-03-31 | $54.00K | $613.85M | $-506.00K | $-272.51M | $340.89M | 3 month · $3.50M | (m) | (m) |
| 2023-12-31 | $44.00K | $497.51M | $-48.00K | $-261.18M | $236.32M | 12 month · $10.87M | (m) | (m) |
| 2023-09-30 | $44.00K | $494.00M | $-248.00K | $-317.58M | $176.22M | 3 month · $2.79M | (m) | (m) |
| 2023-06-30 | $44.00K | $490.79M | $-133.00K | $-291.68M | $199.03M | 3 month · $2.63M | (m) | (m) |
| 2023-03-31 | $43.00K | $486.52M | $-132.00K | $-269.47M | $216.96M | 3 month · $2.50M | (m) | (m) |
| 2022-12-31 | $38.00K | $452.71M | $-219.00K | $-393.51M | $59.02M | 12 month · $9.15M | (m) | (m) |
| 2022-09-30 | $38.00K | $450.01M | $-337.00K | $-369.89M | $79.82M | 3 month · $2.11M | (m) | (m) |
| 2022-06-30 | $38.00K | $447.89M | $-364.00K | $-387.51M | $60.05M | 3 month · $2.46M | (m) | (m) |
| 2022-03-31 | $38.00K | $444.54M | $-223.00K | $-368.42M | $75.93M | 3 month · $2.27M | (m) | (m) |
| 2021-12-31 | $38.00K | $442.26M | $-138.00K | $-347.10M | $95.06M | 12 month · $10.99M | (m) | (m) |
| 2021-09-30 | $38.00K | $440.32M | $-128.00K | $-352.81M | $87.42M | 3 month · $2.02M | (m) | (m) |
| 2021-06-30 | $38.00K | $438.30M | $-126.00K | $-327.68M | $110.54M | 3 month · $3.87M | (m) | (m) |
| 2021-03-31 | $38.00K | $433.85M | $-123.00K | $-297.56M | $136.21M | 3 month · $3.50M | (m) | (m) |
| 2020-12-31 | $37.00K | $430.32M | $-134.00K | $-275.91M | $154.32M | 12 month · $14.50M | (m) | (m) |
| 2020-09-30 | $37.00K | $426.24M | $-60.00K | $-259.98M | $166.24M | 3 month · $3.44M | (m) | (m) |
| 2020-06-30 | $37.00K | $422.29M | $145.00K | $-345.59M | $76.88M | 3 month · $3.79M | (m) | (m) |
| 2020-03-31 | $37.00K | $416.21M | $421.00K | $-336.91M | $79.76M | 3 month · $3.95M | (m) | (m) |
| 2019-12-31 | $37.00K | $412.23M | $-104.00K | $-312.65M | $99.51M | 12 month · $15.64M | (m) | (m) |
| 2019-09-30 | $37.00K | $408.21M | $-15.00K | $-300.07M | $108.16M | 3 month · $3.27M | (m) | (m) |
| 2019-06-30 | $37.00K | $403.33M | $101.00K | $-285.07M | $118.40M | 3 month · $5.20M | (m) | (m) |
| 2019-03-31 | $37.00K | $396.95M | $-75.00K | $-296.22M | $100.69M | 3 month · $3.46M | (m) | (m) |
| 2018-12-31 | $32.00K | $315.60M | $-133.00K | $-269.05M | $46.45M | 12 month · $15.71M | (m) | (m) |
| 2018-09-30 | $32.00K | $312.25M | $-174.00K | $-246.52M | $65.59M | 3 month · $2.58M | (m) | (m) |
| 2018-06-30 | $32.00K | $308.30M | $-125.00K | $-226.23M | $81.97M | 3 month · $8.06M | (m) | (m) |
| 2018-03-31 | $32.00K | $299.11M | $-162.00K | $-200.69M | $98.29M | 3 month · $2.26M | (m) | (m) |
| 2017-12-31 | $32.00K | $295.02M | $-287.00K | $-160.71M | $134.05M | 12 month · $9.13M | $0.00 | (m) |
| 2017-09-30 | $26.00K | $234.52M | $-455.00K | $-148.88M | $85.21M | (m) | (m) | (m) |
| 2017-06-30 | $26.00K | $230.77M | $30.00K | $-125.54M | $105.29M | (m) | (m) | (m) |
| 2017-03-31 | $26.00K | $229.01M | $325.00K | $-106.66M | $122.70M | (m) | (m) | (m) |
| 2016-12-31 | $26.00K | $225.96M | $-52.00K | $-90.02M | $135.92M | 12 month · $6.31M | $0.00 | 12 month · $6.31M |
| 2016-09-30 | $25.00K | $223.81M | $630.00K | $-75.34M | $149.12M | (m) | (m) | (m) |
| 2016-06-30 | $25.00K | $221.96M | $60.00K | $-66.34M | $155.70M | (m) | (m) | (m) |
| 2016-03-31 | $25.00K | $220.55M | $30.00K | $-57.01M | $163.60M | (m) | (m) | (m) |
| 2015-12-31 | $25.00K | $219.12M | $-251.00K | $-49.82M | $169.07M | 12 month · $4.03M | (m) | 12 month · $4.03M |
| 2015-09-30 | $1.00K | (m) | $38.00K | $-47.18M | $-47.14M | (m) | (m) | (m) |
| 2014-12-31 | $1.00K | (m) | (m) | $-20.83M | $-20.83M | (m) | (m) | 12 month · $425.00K |
| 2013-12-31 | (m) | (m) | (m) | (m) | $-3.83M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |